|
Multiple sclerosis
Citations 111-120 of 475 total displayed.
|
Past content
(since Jan 2001):
|
- EDITORIALS
Statins to treat multiple sclerosis: Friend or foe?
- Myla D. Goldman and Jeffrey A. Cohen
Neurology 2008; 71: 1386-1387.
[Full text]
[PDF]
- ARTICLES
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis
- G. Birnbaum, B. Cree, I. Altafullah, M. Zinser, and A. T. Reder
Neurology 2008; 71: 1390-1395.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis
- M. Krumbholz, I. Meinl, T. Kümpfel, R. Hohlfeld, and E. Meinl
Neurology 2008; 71: 1350-1354.
[Abstract]
[Full text]
[PDF]
- ARTICLES
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
- M. Mehling, V. Brinkmann, J. Antel, A. Bar-Or, N. Goebels, C. Vedrine, C. Kristofic, J. Kuhle, R.L.P. Lindberg, and L. Kappos
Neurology 2008; 71: 1261-1267.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
Cross-reactivity between epidemiology and immunology in multiple sclerosis
- Amit Bar-Or and Jack Antel
Neurology 2008; 71: 1132-1133.
[Full text]
[PDF]
- ARTICLES
Dose comparison trial of sustained-release fampridine in multiple sclerosis
- A. D. Goodman, T. R. Brown, J. A. Cohen, L. B. Krupp, R. Schapiro, S. R. Schwid, R. Cohen, L. N. Marinucci, A. R. Blight For the Fampridine MS-F202 Study Group
Neurology 2008; 71: 1134-1141.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults
- H. Wang, K. L. Munger, M. Reindl, E. J. O’Reilly, L. I. Levin, T. Berger, and A. Ascherio
Neurology 2008; 71: 1142-1146.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Diagnosing disconjugate eye movements: Phase-plane analysis of horizontal saccades
- Alessandro Serra, Ke Liao, Manuela Matta, and R. John Leigh
Neurology 2008; 71: 1167-1175.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
VERBAL MEMORY DEFICIT FOLLOWING TRAUMATIC BRAIN INJURY: ASSESSMENT USING ADVANCED MRI METHODS
- C. L. MacDonald, N. Schwarze, S. N. Vaishnavi, A. A. Epstein, A. Z. Snyder, M. E. Raichle, J. S. Shimony, and D. L. Brody
Neurology 2008; 71: 1199-1201.
[Full text]
[PDF]
- ARTICLES
Vanishing MS T2-bright lesions before puberty: A distinct MRI phenotype?
- D. Chabas, T. Castillo-Trivino, E. M. Mowry, J. B. Strober, O. A. Glenn, and E. Waubant
Neurology 2008; 71: 1090-1093.
[Abstract]
[Full text]
[PDF]
|
|
